You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

GSK’s primary therapy areas

Respiratory

Respiratory

GSK UK information about our respiratory portfolio, as well as resources and latest news.

Vaccines

Vaccines

GSK UK information about our vaccines portfolio, as well as resources and latest news.

 

GSK’s other therapy areas

Allergy

Allergy

GSK UK information about our allergy portfolio.

Anti-infectives

Anti-infectives

GSK UK information about our anti-infectives portfolio.

Cardiovascular

Cardiovascular

GSK UK information about our cardiovascular portfolio.

Dermatology

Dermatology

GSK UK information about our Stiefel dermatology products.

Gastroenterology

Gastroenterology

GSK UK information about our gastroenterology portfolio.

Influenza

Influenza

GSK UK information about our influenza portfolio.

HIV

HIV

Information about ViiV Healthcare UK’s HIV portfolio.

Musculoskeletal

Musculoskeletal

GSK UK information about our musculoskeletal portfolio.

Neurology

Neurology

GSK UK information about our neurology portfolio.

Rare diseases

Rare diseases

GSK UK information about our rare diseases portfolio.

Urology

Urology

GSK UK information about our urology portfolio.

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to GlaxoSmithKline UK on 0800 221 441.

M.C. Last updated: February 2018. UK/COM/0106/15s(2)